Alumis, Inc. (ALMS)
25.50
-0.62
(-2.39%)
USD |
NASDAQ |
May 06, 16:00
25.50
0.00 (0.00%)
After-Hours: 17:28
Alumis EPS Diluted (Quarterly) : -0.8875 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.308 |
| Nektar Therapeutics | -1.778 |
| Oramed Pharmaceuticals, Inc. | 0.2274 |
| Aclaris Therapeutics, Inc. | -0.1614 |
| Crinetics Pharmaceuticals, Inc. | -1.292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -92.93M |
| Revenue (Quarterly) | 1.929M |
| Total Expenses (Quarterly) | 94.86M |
| Enterprise Value | 3.052B |
| Gross Profit Margin (Quarterly) | 55.05% |
| Profit Margin (Quarterly) | -4.82K% |
| Earnings Yield | -11.76% |
| Normalized Earnings Yield | -10.81 |